| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Acer Therapeutics Inc (NASDAQ: ACER)
ACER Technical Analysis
5
| As on 9th Jun 2023 ACER STOCK Price closed @ 0.96 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.87 & Strong Sell for SHORT-TERM with Stoploss of 2.30 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ACERSTOCK Price
| Open | 0.95 | Change | Price | % |
| High | 0.97 | 1 Day | 0.02 | 2.13 |
| Low | 0.93 | 1 Week | 0.07 | 7.87 |
| Close | 0.96 | 1 Month | 0.08 | 9.09 |
| Volume | 132656 | 1 Year | -1.28 | -57.14 |
| 52 Week High 4.15 | 52 Week Low 0.67 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ACER Daily Charts |
ACER Intraday Charts |
Whats New @ Bazaartrend |
ACER Free Analysis |
|
|
ACER Important Levels Intraday
| RESISTANCE | 1.04 |
| RESISTANCE | 1.01 |
| RESISTANCE | 1.00 |
| RESISTANCE | 0.98 |
| SUPPORT | 0.94 |
| SUPPORT | 0.92 |
| SUPPORT | 0.91 |
| SUPPORT | 0.88 |
ACER Forecast May 2024
| 4th UP Forecast | 2.41 |
| 3rd UP Forecast | 1.94 |
| 2nd UP Forecast | 1.66 |
| 1st UP Forecast | 1.37 |
| 1st DOWN Forecast | 0.55 |
| 2nd DOWN Forecast | 0.26 |
| 3rd DOWN Forecast | -0.02 |
| 4th DOWN Forecast | -0.49 |
ACER Weekly Forecast
| 4th UP Forecast | 1.48 |
| 3rd UP Forecast | 1.31 |
| 2nd UP Forecast | 1.21 |
| 1st UP Forecast | 1.11 |
| 1st DOWN Forecast | 0.81 |
| 2nd DOWN Forecast | 0.71 |
| 3rd DOWN Forecast | 0.61 |
| 4th DOWN Forecast | 0.44 |
ACER Forecast2024
| 4th UP Forecast | 8.49 |
| 3rd UP Forecast | 6.08 |
| 2nd UP Forecast | 4.58 |
| 1st UP Forecast | 3.09 |
| 1st DOWN Forecast | -1.17 |
| 2nd DOWN Forecast | -2.66 |
| 3rd DOWN Forecast | -4.16 |
| 4th DOWN Forecast | -6.57 |
Acer Therapeutics Inc ( NASDAQ USA Symbol : ACER )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ACER Business Profile
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates: EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-001, a formulation of sodium phenylbutyrate for the treatment of various inborn errors of metabolism, including urea cycle disorders and maple syrup urine disease; ACER-801 (osanetant) for the treatment of induced Vasomotor Symptoms; and ACER-2820 (emetine), a host-directed therapy against a variety of infectious diseases, including COVID-19. The company has a research collaboration agreement with the National Center for Advancing Translational Sciences (NCATS) to develop emetine hydrochloride as a potential treatment for patients with COVID-19; and a license agreement with Sanofi to acquire worldwide rights to osanetant, a clinical-stage, selective, and non-peptide tachykinin NK3 receptor antagonist. Acer Therapeutics Inc. was founded in 1991 and is headquartered in Newton, Massachusetts. Address: One Gateway Center, Newton, MA, United States, 02458
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service